GENinCode plc announces intention to float on AIM of London Stock Exchange
LONDON, UK: GENinCode plc, cardiovascular disease (CVD) risk assessment company, has expressed intention to seek admission of its issued and to be issued Ordinary Shares to trading on AIM, a market of the London Stock Exchange. On admission, the Company…